Trial Profile
Pre-operative chemotherapy with mFOLFOX6+Bevacizumab in liver only metastases from colorectal cancer -Phase II feasibility study-
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 May 2017
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms FITS 0801
- 16 May 2016 New trial record